New paper demonstrates formation of spontaneously active neuronal networks by stem cell derived neurons in 3D Alvetex Scaffold culture system
05 March 2015
A recently published paper by Imogen Smith et al. demonstrates the use of the Alvetex platform to culture 3D differentiated human neural stem cells.
RSC book publication: Human-based systems for translational research
02 February 2015
Read about the REPROCELL Europe CEO's newly published review of functional human tissue assays in a new book entitled Human-based systems for translational research
Biopta and Proteon publish new research in Journal of Cardiovascular Pharmacology
13 January 2015
A new paper in the Journal of Cardiovascular Pharmacology describes a potential treatment for atherosclerosis.
Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)
05 August 2014
Read about the Japanese regenerative medicine company REPROCELL Inc. and its acquisition of Reinnervate Ltd. (UK), and BioServe Inc. of MD, USA.
Scottish company creates first searchable database of human pharmacological responses in functional intact tissues
25 February 2014
Biopta Ltd, the human tissue-based contract research organisation, today announced a major development in discovery research with the launch of the first catalog of assays based on human functional tissues.
Biopta collaborates with Merck to investigate in vivo cardiac effects
13 November 2013
In a recent collaboration with Merck, Biopta conducted human functional tissue experiments to investigate the mechanisms underlying two anti-arrhythmic drugs.
Scottish SMEs Announce Collaboration with Universities, Industry and NHS in Establishment of a £20m Stratified Medicine Scotland Innovation Centre
23 April 2013
Today Scotland’s First Minister Alex Salmond announced the creation of a £20M Stratified Medicine Scotland Innovation Centre (SMS-IC), at the new South Glasgow Hospitals Campus.